(HealthDay)—The incidence of myocarditis is low but increased among individuals aged 16 years and older who have received the Pfizer-BioNTech BNT162b2 mRNA vaccine, with the highest incidence among young men, according ...
Oct 13, 2021
0
38
Researchers believe they have identified a way to prevent type 1 diabetes by restoring the immune system's natural balance. The approach may also prove effective for battling other autoimmune diseases such as lupus and eczema, ...
Sep 26, 2019
0
113
With obesity now affecting almost a third (29%) of the population in England, and expected to rise to 35% by 2030, should we now recognise it as a disease? Experts debate the issue in The BMJ today.
Jul 18, 2019
2
454
Progress on a COVID-19 vaccine has propelled the modest husband-and-wife team behind German firm BioNTech into the global limelight, with attention inevitably focussing on their background as the children of Turkish immigrants.
Nov 14, 2020
0
8
MYC genes and their proteins play a central role in the emergence and development of almost all cancers. They drive the uncontrolled growth and altered metabolism of tumor cells. And they help tumors hide from the immune ...
Nov 23, 2022
0
309
Scientists at Simon Fraser University (SFU) and the Lankenau Institute for Medical Research (LIMR) near Philadelphia have found that a drug discovered at SFU and patented several years ago may have potential lifesaving results ...
May 10, 2023
0
69
For the 2021 to 2022 influenza season, influenza vaccines were 36 percent effective against influenza A(H3N2)-related illnesses, according to a study published online Dec. 12 in Clinical Infectious Diseases.
Jan 4, 2023
0
22
Withdrawal symptoms following the practice of discontinuation, or abruptly "coming off," of psychiatric drugs in randomized clinical trials may be mistaken for relapse and bolster the case for continued use of medication, ...
Apr 22, 2019
0
15
Patients with schizophrenia face persistent inequality in educational attainment, according to a review published online in the July issue of The Lancet Psychiatry.
Jun 23, 2022
0
10
(HealthDay)—A five-day course of ivermectin does not improve the time to resolution of symptoms compared with placebo for adults with mild COVID-19, according to a study published online March 4 in the Journal of the American ...
Mar 5, 2021
0
7
